
Arcturus Therapeutics Holdings Inc (ARCT)
US$ 12.85.35%
Price Chart
Key Statistics
Market Cap
$ 347.41M
P/E Ratio
0.00
Revenue (TTM)
$ 143.68M
Volume
349.42K
52W High
$ 45.00
52W Low
$ 8.04
Dividend Yield
0.00%
Beta
2.29
Technicals
50-Day MA
11.4992
200-Day MA
16.6898
52 Week High
45
52 Week Low
8.04
About ARCT
Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
Employees
174
Headquarters
San Diego, CA
CEO
Mr. Joseph E. Payne M.Sc.
Latest News
Arcturus Therapeutics to Attend Upcoming Investor Conferences - Business Wire
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg